ClinicalTrials.gg

Pharyngitis clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 227 studies for Pharyngitis across more than 10 countries. 36 are recruiting or about to start. 121 of them are mainly about Pharyngitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its narrower condition Tonsillitis too: 310 studies, 45 open.

Status

Completed
146
Status unknown
27
Recruiting
19
Not yet recruiting
14
Terminated
10
Withdrawn
5

Phase

Phase 3
39
Phase 4
25
Phase 2
14
Phase 1
5
Early Phase 1
3

Where

United States
41
Turkey
26
Germany
13
Canada
11
Korea, Republic of
11
France
10

Who develops what

Add Pharyngitis to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 2 programs from 1 company, 2 with this as their studies’ main aim; 0 with a live phase 3 study; 1 primary completion in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
AcetaminophenEarlier only
Evidence
  • NCT01465009 · Bayer · Phase 4 · comparator · “Paracetamol” · registered May 2011
  • NCT01048866 · Reckitt · Phase 3 · background · “acetaminophen 650mg” · registered Jan 2010
Johnson & Johnson29% of its industry studiesUS: off-patent, 109 generics marketed00 studies

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 2 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (1)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 31 Dec 2026 est.Gramicidin · Valenta Pharm JSC · Phase 2 main aimNCT06843018 Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With Anesthetic, a Metered Dose Topical Spray, in the Treatment of Acute Infectious and Inflammatory Pharyngeal Diseases Compared With Drug Septolete Total, Lozenges — primary endpoint: Combined primary efficacy endpoint: VAS + TPA · 300 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

Coming up

15studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 19 Pharyngitis studies recruiting now, 5 (26%) set no upper age limit and 10 (53%) stop at 75 or younger. 8 (42%) take children under 18. 3 (16%) are for women only and 0 (0%) for men only; 5 (26%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
107 (37%)6 (32%)
1815 (79%)14 (74%)
3016 (84%)14 (74%)
4016 (84%)14 (74%)
5014 (74%)12 (63%)
6512 (63%)10 (53%)
7510 (53%)9 (47%)
857 (37%)7 (37%)

Across all 227 studies, recruiting or not: 47% stop at 75 or younger and 39% at 65; 33% take children; 4% are for women only and 0% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pharyngitis studies take

Of 13 phase 3 interventional studies under Pharyngitis, half reached primary completion within 3 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 33 mo2–6 · 13 studies——
Interventional, no phase10 mo5–17 · 63 studies—9 mo5–17 · 58 studies
Observational20 mo10–29 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 227. Browse all 227 → or search them.